Journal articleHuman

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

Gastroenterology, 2008 Jan. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT and 3 others.

Study type

Journal article

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Gastroenterology

Published

2008 Jan

PubMed

PMID 18061177 ↗

DOI

10.1053/j.gastro.2007.10.026 ↗

Full text

Free on PubMed Central (PMC2431115) ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

KPV →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AnimalsCell Culture TechniquesCell Line, TumorChemokinesColitisDisease Models, AnimalEpithelial CellsFemaleHumansIntestinal MucosaMelanocyte-Stimulating HormonesMice

Other papers on KPV

Observational study · 2008

Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease

Review · 2008

Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases

Journal article · 2003

Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page